how to switch from semaglutide to retatrutide Tirzepatide Retatrutide vs Semaglutide: Triple Agonist

Clinical Safety Panel - GLP-1 Weight Loss Programs GLP-1 medications are prescribed only after a medical evaluation by a licensed provider Treatment is recommended only when clinically appropriate Personalized dosing is used to support safety and tolerance Dose adjustments are made gradually based on patient response Potential side effects and risks are reviewed before starting treatment Ongoing monitoring is provided throughout the program Treatment plans may be adjusted or stopped based on clinical need GLP-1 therapy is part of a comprehensive medical weight loss program Individual results vary, and medical supervision is required Medical Disclaimer This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease

High-intensity exercise should be approached with caution during the first two to four weeks

J.et al (2009)

Pre-filled tirzepatide pens typically remain effective for up to 8 weeks after opening, if they are kept in a refrigerator

A GP or specialist referral may be required to assess eligibility for participation